CPD Events
Matching treatment goals to technology: the role of inhaler selection for patients with COPD
11 Feb 2025
About the event
AstraZeneca’s Transforming COPD care webinar series aims to highlight the current challenges associated with COPD management and how these could be addressed by optimising maintenance therapy and interventions to reduce exacerbations. Supported by the discussion of relevant data and publications; this webinar will aim to highlight the potential clinical benefits of prescribing TRIXEO for COPD disease management in uncontrolled patients on dual therapy.
Send an enquiry
AstraZeneca UK (Central Membership)
A global pharmaceutical company with a major UK presence. Our purpose is to push the boundaries of science to deliver life-changing medicines. The best way we can help patients is to be science-led and share this passion with the scientific, healthcare and business communities of the UK.
Want to learn more?
Similar CPD Events
Healthcare & Medical
Matching treatment goals to technology: the role o...
AstraZeneca UK (Central Membership)
AstraZeneca’s Transforming COPD care webinar series aims to highlight the current challenges associa...
26 Feb 2025